The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combined treatment of durvalumab, bevacizumab and tremelimumab in subjects with hepatocellular carcinoma (HCC) or biliary tract carcinoma (BTC).
 
Joy Awosika
No Relationships to Disclose
 
M. Cecilia Monge B.
No Relationships to Disclose
 
Changqing Xie
No Relationships to Disclose
 
Nebojsa Skorupan
No Relationships to Disclose
 
David Kleiner
(OPTIONAL) Uncompensated Relationships - HighTide Therapeutics, Inc.; HistoIndex
 
Donna Mabry Hrones
No Relationships to Disclose
 
Brad Wood
No Relationships to Disclose
 
Bernadette Redd
Consulting or Advisory Role - 2020DX (I); Abbvie (I)
 
Tim Greten
No Relationships to Disclose